Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Canada

US FDA Bans Selected Apotex Exports

September 2009 | Industry Trend Analysis

Canadian generic drugmaker Apotex has had a US import ban imposed on selected products by the US FDA. The decision follows a factory inspection by the US regulatory authority which concluded that manufacturing processes had deviated from FDA requirements. While only two plants have been immediately affected by this action, Apotex has fully co-operated with the US FDA to resolve the issues as quickly as possible.

To read the full article, please choose one of the following options:

Subcribers please log in